1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with taxane in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (taxane) | Trials (taxane) | Recent Studies (post-2010) (taxane) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,288 | 210 | 779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldring, WP; Pattenden, G | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and taxane
| Article | Year |
|---|---|
The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes.
Topics: Animals; Bridged-Ring Compounds; Epoxy Compounds; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Structure; Platelet Activating Factor; Taxoids | 2006 |